phenyl acetate has been researched along with Cranial Nerve IV Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burdon, M; Deokule, S; Matthews, T | 1 |
Kosmorsky, GS; Leigh, RJ; Tomsak, RL | 1 |
1 trial(s) available for phenyl acetate and Cranial Nerve IV Diseases
Article | Year |
---|---|
Gabapentin attenuates superior oblique myokymia.
Topics: Acetates; Administration, Oral; Adult; Amines; Cyclohexanecarboxylic Acids; Diplopia; Excitatory Amino Acid Antagonists; Eye Movements; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Treatment Outcome; Trochlear Nerve Diseases | 2002 |
1 other study(ies) available for phenyl acetate and Cranial Nerve IV Diseases
Article | Year |
---|---|
Superior oblique myokymia improved with gabapentin.
Topics: Acetates; Administration, Oral; Aged; Amines; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Trochlear Nerve Diseases | 2004 |